Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

How Private Equity Oversees the Ethics of Drug Research

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.

Walt Bogdanich
Author: Walt Bogdanich

Written by

Walt Bogdanich

in

Clinical Trials, Conflicts of Interest, Drugs (Pharmaceuticals), Ethics and Official Misconduct, GLP-1 RAs (Drug), Mergers, Acquisitions and Divestitures, Novo Nordisk A/S, Ozempic (Drug), Private Equity, Regulation and Deregulation of Industry, Research
←An American Way of Dress
More Retirees Are Living on Less, and Losing a Means of Help to Pay for Medicare→

More posts

  • Disney Offers $20M For Character.AI Assets As Startup Files For Chapter 11 Bankruptcy Protection

  • Trump has asked Kimberly Guilfoyle to resign, White House says

  • Controversial ‘Downstate’ Delays First Broadway Preview Due To Illness

  • Getting Booked: Here’s What 5 Models Read Backstage During the Spring 2027 Season

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube